← Back to Vaccine Database

SARS-CoV-2 mRNA vaccine (ARCoV)

RNA based vaccine · VDDBV0676

Target & Classification

SARS-CoV-2SARS-CoV-2
RNA based vaccine
COVID-19
Phase 3

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT04847102 Phase 3COVID-19